Terra Innovatum Global N.V. (NASDAQ: NKLR) generates news as a developer of micro-modular nuclear reactors focused on its SOLO™ Micro-Modular Reactor platform. Company announcements frequently center on regulatory progress with the U.S. Nuclear Regulatory Commission (NRC), manufacturing partnerships, investor communications, and early-stage commercial agreements. For readers tracking developments in nuclear energy, data center infrastructure, and clean power solutions, NKLR news provides insight into how the SOLO concept is advancing toward deployment.
Recent press releases highlight Terra Innovatum’s expanded NRC engagement, including topical reports on reactor module design, core design using commercially available low-enriched uranium fuel, emergency planning zone analysis, first-of-a-kind siting, and defense-in-depth safety features. News items also cover the company’s outsourced manufacturing model, such as the agreement with ATB Riva Calzoni in Italy to establish SOLO manufacturing processes, assembly lines, and logistics for first-of-a-kind and commercial units.
Investors and industry observers can also follow NKLR news for updates on commercial activity. Terra Innovatum has reported non-binding MOUs and letters of intent, including a pilot program with Uvation Inc. to power AI-focused data centers with SOLO, as well as an identified deployment site in Illinois with potential for multiple SOLO units. Additional coverage includes participation in major nuclear and clean energy conferences and the company’s transition to trading on Nasdaq following a business combination.
This news feed brings together these disclosures so readers can monitor Terra Innovatum’s regulatory milestones, manufacturing readiness, conference participation, and commercial discussions around the SOLO micro-modular reactor.
Terra Innovatum (NKLR) has shared 12 draft safety-report chapters with U.S. nuclear regulators as it advances its SOLO reactor construction-permit application. The chapters represent 12 of 18 planned sections of its Preliminary Safety Analysis Report. The company targets delivery of the remaining six by October 30, 2026 and expects the next readiness-review milestone by the end of November, subject to NRC scheduling. Formal application submission is expected after the readiness review.
Terra Innovatum targets its first reactor deployment in 2027 and broader deployment beginning in 2028. It expects existing resources to cover the first reactor's licensing, manufacturing, construction and initial operations without additional equity under its current plan; cash and cash equivalents totaled $91.1 million at June 30, 2026. Procurement and down payments have begun for graphite components, a turbine and generator, and an air-cooled condenser.
Terra Innovatum (NASDAQ: NKLR) advanced manufacturing preparations and equipment testing for its SOLO micro-modular reactor with industrial partners ATB and Boldrocchi. The company targets deployment of its first-of-a-kind reactor in 2027.
With ATB Riva Calzoni, Terra Innovatum developed manufacturing procedures, reviewed assembly workflows and evaluated factory space and production configurations. The partners are establishing manufacturing trials to validate assembly methods and production processes; that validation remains underway.
At Boldrocchi, Terra Innovatum oversaw a four-hour hot-running test of a helium circulator with the same design intended for SOLO's cooling loop. Two additional helium blowers are being prepared for non-nuclear system testing to assess circulation performance and component interfaces. These activities advance equipment qualification and preparations for reactor assembly, rather than completed reactor construction.
Terra Innovatum (NASDAQ: NKLR) announced management participation in three upcoming investor conferences in New York City to meet institutional investors. The schedule includes the ROTH Emerging Nuclear Technology Conference on October 1, 2026, Clear Street’s 2nd Annual Disruptive Technology Conference on November 18–20, and the B. Riley Convergence Conference on December 2, 2026.
At the invitation-only ROTH event, the company will join a working-lunch industry panel and hold one-on-one and small-group investor meetings. Management will discuss progress across SOLO™ reactor licensing, industrialization and commercialization during its investor outreach.
Terra Innovatum (NKLR) welcomed the Italian Parliament’s approval of a nuclear-energy framework on September 24, 2026. The legislation covers advanced nuclear technologies and small modular reactors. Italy’s government is expected to develop implementing measures for licensing, safety, waste management and siting.
At the 70th IAEA General Conference, Italy presented Terra Innovatum’s SOLO as a domestic microreactor solution. Terra Innovatum is developing the reactor and advancing it through the U.S. Nuclear Regulatory Commission licensing process. The company describes approximately $4 billion in pre-commercial commitments globally. It targets approvals required for first-of-a-kind deployment by the end of 2027, followed by commercial deployment and scale-up by the end of 2028. As Italy develops its implementing measures, Terra Innovatum intends to evaluate opportunities in the Italian market.
Terra Innovatum (NKLR) has appointed three new independent directors, Michael Modro, Kostadin Ivanov and Tony Tullio, to its Board effective September 22, 2026.
Their appointments will be submitted for confirmation at the next Annual General Meeting. The new directors add expertise in nuclear safety, licensing, reactor physics, engineering, and financial and operational leadership in complex, regulated industrial businesses. Michael W. Howard, Rex S. Jackson and Peter Hastings have stepped down, while Joanna Lohkamp remains on the Board.
The Board plans to create a Technology, Safety and Licensing Committee, subject to adoption of governance documents, to oversee the SOLO™ micro‑modular reactor platform, nuclear safety, licensing strategy and related technical and deployment activities as Terra Innovatum moves from development toward commercialization.
Terra Innovatum (NASDAQ: NKLR) announced that the U.S. Nuclear Regulatory Commission has begun the first phase of a limited-scope preapplication readiness assessment for defined portions of the planned Construction Permit Application for its first-of-a-kind SOLO™ Micro-Modular Reactor.
The six-week phase, launched after an August 10, 2026 entrance meeting, will review Terra Innovatum’s Environmental Report and nine selected Preliminary Safety Analysis Report chapters covering facility, site, reactor description, safety features, radiation and waste, financial qualifications, other license considerations, decommissioning and uranium fuel conversions. A multidisciplinary NRC team will conduct the review, which is intended to identify information gaps ahead of formal CPA filing and will conclude with an exit meeting and a public feedback report.
Terra Innovatum (NASDAQ:NKLR) reported second quarter 2026 results, highlighting cash and cash equivalents of $91.1 million as of June 30, 2026. Total operating expenses and loss from operations were $6.1 million, including $4.6 million of general and administrative expenses and $1.5 million of development costs. Net loss for the quarter was $18.0 million, or $0.16 per basic and diluted share, including $13.2 million of non-cash fair-value remeasurement expense related to share-settled contingent and warrant liabilities.
Operationally, Terra Innovatum advanced an initial commercial pathway for up to 8 MWe of behind-the-meter SOLO™ capacity for data centers in Argentina and Brazil, progressed NRC engagement and U.S. commercialization activities, and strengthened manufacturing and supply-chain relationships to support FOAK deployment and future scale-up. The company will host a webinar and conference call on August 27, 2026 at 8:00am ET to discuss results and operational priorities.
Terra Innovatum (NASDAQ:NKLR) will participate in Canaccord Genuity’s 46th Annual Growth Conference, held August 11–13, 2026 at the InterContinental Boston. Chief Strategy Officer and SOLO Safeguards Director Massimo Morichi will deliver a live presentation and Q&A on Wednesday, August 12, 2026 at 9:30 a.m. ET in the Rose Kennedy II room.
The session will be webcast live via a dedicated link and the Terra Innovatum investor relations site. Management will also conduct one-on-one meetings with institutional investors and attend the conference’s Taste of Boston event. According to Terra Innovatum, management plans to discuss its commercial strategy, technology platform, and progress toward deployment of the SOLO Micro-Modular Reactor (SMR), aimed at providing scalable, CO2-free nuclear power for diverse applications.
Terra Innovatum (NASDAQ: NKLR) announced that its common shares were added to the Solactive Global Uranium & Nuclear Components Total Return Index, effective at the open of trading on August 3, 2026. This index is the benchmark tracked by the Global X Uranium ETF (URA), a major uranium and nuclear sector ETF.
According to Terra Innovatum, inclusion in this rules-based index, administered solely by Solactive AG, places the company among global firms across the nuclear fuel cycle and expands its visibility to institutional, retail, passive, and thematic investors as it advances its SOLO™ micro-modular reactor program toward first-of-a-kind deployment.
Terra Innovatum (NASDAQ:NKLR) has asked the U.S. Nuclear Regulatory Commission to conduct a voluntary preapplication readiness review for its planned SOLO™ Micro-Modular Reactor Construction Permit Application, which Terra aims to submit in 2026 to support a 2028 commercialization objective.
The NRC review would assess draft sections of Terra's Preliminary Safety Analysis Report and Environmental Report starting July 2026, with the company requesting review commencement in August 2026. According to Terra, this early engagement is intended to identify technical, regulatory and administrative issues in advance, improve application quality, and support its parallel construction permit and operating license strategy.